Clinical trial
Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid…
NCT00091052 · Sirius Medicine, Industry · Completed
Key facts
| NCT number | NCT00091052 |
|---|---|
| Title | Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors |
| Official title | Contrast-Enhanced Radiotherapy With GM-CSF Immune Stimulation - Phase I/II Clinical Center Treatment Trial |
| Lead sponsor | Sirius Medicine, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Radiation |
| Interventions | sargramostim, radiation therapy |
| Start date | Jul 1, 2004 |
| Completion | Jun 1, 2006 |
| First posted | Sep 8, 2004 |
| Last update posted | Mar 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: